Search En menu ClientConnect
Top 5 search results See all results Advanced search
Top searches
Most visited pages
    Reference: 20150860
    Release date: 1 February 2016

    Promoter – Financial Intermediary




    Financing of the second phase of the investment programme of the University Hospital in Maastricht to be implemented over the period 2015 to 2019


    The project will support the infrastructure and organisational development of the Academisch Ziekenhuis Maastricht (University Hospital Maastricht - azM) in Maastricht, the Netherlands.


    Proposed EIB finance (Approximate amount)

    EUR 105 million

    Total cost (Approximate amount)

    EUR 315 million

    Environmental aspects

    Hospitals are not specifically mentioned in the Environmental Impact Assessment (EIA) Directive 2011/92/EU, though the project is covered by Annex II of the directive in relation to urban development. The Bank's services will verify the screening decision of the competent authority during appraisal and whether an EIA is required. It is expected that the project will have positive social benefits as healthcare is an element of social cohesion.


    The Bank will require the promoter to ensure that contracts for the implementation of the project have been/shall be tendered in accordance with the relevant applicable EU procurement legislation (Directive 2004/18/EC and/or 2004/17/EC as well as Directives 89/665/EEC and 92/13/EEC) as interpreted by the Court of Justice of the EU, with publication of tender notices in the EU Official Journal, as and where required.


    Signed - 14/12/2016


    Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The data provided on this page is therefore indicative and cannot be considered to represent official EIB policy (see also the Explanatory notes).

    Related tags

    The Netherlands Health